TherapeuticsMD Inc logo

TXMD - TherapeuticsMD Inc News Story

$0.305 -0.0  -2.7%

Last Trade - 9:00pm

Small Cap
Market Cap £98.3m
Enterprise Value £158.7m
Revenue £67.0m
Position in Universe 5174th / 7405

TherapeuticsMD Inc reports results for the quarter ended in March - Earnings Summary

Thu 6th May, 2021 3:45pm
* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss of 11 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 12 cents per share.
* Revenue rose 62.2% to $19.87 million from a year ago​; 
analysts expected $19.77 million.
* TherapeuticsMD Inc's reported EPS for the quarter was a loss
of 11 cents​.
* The mean earnings estimate of analysts had fallen by
about 12.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* TherapeuticsMD Inc shares had fallen by 4.5% this quarter and
gained 5.8% so far this year.
* The company reported a quarterly loss of $39.38 million.
* Wall Street's median 12-month price target for TherapeuticsMD
Inc is $5.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 6 at 02:45 p.m. GMT. ​All
figures in US Dollars.​
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.